查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
動物用治療藥及診斷藥的全球市場-機會分析及產業預測:各產品類型，各動物類型(寵物，牛，豬，家禽，綿羊)(2020年～2030年)
市場調查報告書
商品編碼
1090751

動物用治療藥及診斷藥的全球市場-機會分析及產業預測:各產品類型，各動物類型(寵物，牛，豬，家禽，綿羊)(2020年～2030年)

Animal Therapeutics and Diagnostics Market By Product Type (Animal Diagnostics Products, Animal Therapeutics Products), By Animal Type (Companion Animals, Cattle, Pigs, Poultry, Sheep): Global Opportunity Analysis and Industry Forecast, 2020-2030
出版日期: | 出版商: Allied Market Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

全球動物用治療藥及診斷藥的市場規模預計將從2020年的334億6,250萬美元，到2030年達到590億8,210萬美元，在預測期間內預計將以5.9％的年複合成長率增長。

由於對牲畜和寵物的動物健康知識的增加以及世界各地伴侶動物的擴散，預計市場將在整個預測期內適度增長。

本報告提供全球動物用治療藥及診斷藥市場相關調查分析，提供市場形勢，市場分析，企業簡介等系統性資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
    • 主要的投資口袋
  • 波特的五力分析
  • 主要企業的定位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 市場上的COVID-19影響分析

第4章 動物用治療藥及診斷藥市場:各產品類型

  • 概要
  • 動物診斷產品
  • 動物用治療產品

第5章 動物用治療藥及診斷藥市場:各動物類型

  • 概要
  • 寵物
  • 牛
  • 豬
  • 家禽
  • 綿羊

第6章 動物用治療藥及診斷藥市場:各地區

  • 市場規模與預測
  • 主要趨勢和機會
  • 北美市場規模與預測:產品類型
  • 北美市場規模與預測:各動物類型
  • 北美市場規模與預測:各國
    • 美國
    • 加拿大
    • 墨西哥
  • 主要趨勢和機會
  • 歐洲市場規模與預測:產品類型
  • 歐洲市場規模與預測:各動物類型
  • 歐洲市場規模與預測:各國
    • 德國
    • 法國
    • 英國
    • 義大利
    • 其他的歐洲
  • 主要趨勢和機會
  • 亞太地區市場規模與預測:各產品類型
  • 亞太地區市場規模與預測:各動物類型
  • 亞太地區市場規模與預測:各國
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他的亞太地區
  • 主要趨勢和機會
  • 南美·中東·非洲市場規模與預測:各產品類型
  • 南美·中東·非洲市場規模與預測:各動物類型
  • 南美·中東·非洲市場規模與預測:各國
    • 南美
    • 中東
    • 非洲

第7章 企業形勢

  • 簡介
  • 主要的成功策略
  • 主要十大公司的產品製圖
  • 競爭儀表板
  • 競爭熱圖
  • 主要的開發

第8章 企業簡介

  • Bayer AG
  • Eli Lilly and Company
  • Boehringer
  • Ingelheim GmbH
  • Merck and Co.
  • Zoetis Inc.
  • Ceva Sante Animale
  • Sanofi S.A.
  • Nutreco N.V.
  • Virbac S.A.
Product Code: A01619

The global animal therapeutics and diagnostics market was valued at $33,462.5 million in 2020, and is projected to reach $59,082.1 million by 2030, registering a CAGR of 5.9% from 2021 to 2030. Animal therapeutics includes a variety of therapeutic items that may be used to treat many diseases. Various tests and techniques are utilized in the diagnosis of any diseases in animals. Both animal diagnostics and animal therapies are critical for illness treatment. The sustainability of animal health becomes increasingly important as human dependency on animals for daily necessities such as meat, protein, and milk grows. Diseases are diagnosed using a variety of diagnostic tests and devices, whereas therapy solutions are administered using medications based on their mechanism of action. Majority of the diagnostic tests and treatment products are required by veterinary clinics.

The market is predicted to grow at a moderate rate throughout the forecast period, owing to increase in knowledge about animal health in livestock and pet animals as well as surge in adoption of companion animals around the world. In addition, rise in meat & milk consumption and alarming increase in prevalence of zoonotic illnesses significantly contribute toward the market expansion. However, high costs of diagnosis and therapeutic treatments and overuse of drugs in animals can have a severe impact on public and animal health, thus hindering the market growth. Furthermore, lack of understanding about animal welfare among pet owners can stifle the growth of the animal diagnostics and therapeutics industry.

Key players in animal therapeutics and diagnostics are launching various test kits and diagnostics kits to monitor animals' behavior and health. For instance, in October 2021, Zoetis Inc., manufacturer of animal medicines and vaccines, launched digital cytology testing to its Vetscan Imagyst product. In addition to AI technology for fecal testing, Vetscan Imagyst now provides a network of skilled remote pathologists. Furthermore, in June 2021, Zoetis Inc. expanded its equine orse care products by introducing Restigen, PRP, Pro-Stride APS, and CenTrateBMA. These devices are designed to address injuries in horses that may cause limping. Introduction of such products is a key factor fostering the market growth.

The market is segmented into product type, animal type industry, and region. Depending on product type, the market is classified into animal diagnostics products and animal therapeutics products. By animal type, it is classified as companion animals, cattle, pigs, poultry, and sheep. Region wise, the global market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

COMPETITION ANALYSIS

The key players operating in the global animal therapeutics and diagnostics are Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Idexx Laboratories Inc., Ceva Sante Animale, Sanofi S.A., Heska Corporation, Thermo Fisher Scientific Inc., and Randox Laboratories Ltd.

Key Benefits For Stakeholders

  • The report provides an extensive analysis of the current and emerging animal therapeutics and diagnostics market trends and dynamics.A 
  • In-depth animal therapeutics and diagnostics market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
  • The global animal therapeutics and diagnostics market share analysis from 2020 to 2030 is included in the report.
  • Extensive analysis of the animal therapeutics and diagnostics market size is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
  • The global animal therapeutics and diagnostics market forecast analysis from 2021 to 2030 is included in the report.
  • The key players which contributed to the animal therapeutics and diagnostics market growth are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the animal therapeutics and diagnostics industry.

Key Market Segments

By Product Type

  • Animal Diagnostics Products
  • Animal Therapeutics Products

By Animal Type

  • Companion Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
  • Key Market Players
    • Bayer AG
    • Eli Lilly and Company
    • Boehringer
    • Ingelheim GmbH
    • Merck and Co.
    • Zoetis Inc.
    • Ceva Sante Animale
    • Sanofi S.A.
    • Nutreco N.V.
    • Virbac S.A.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Animal Diagnostics Products
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Animal Therapeutics Products
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Companion Animals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Cattle
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Pigs
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Poultry
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country
  • 5.6 Sheep
    • 5.6.1 Key market trends, growth factors and opportunities
    • 5.6.2 Market size and forecast, by region
    • 5.6.3 Market analysis by country

CHAPTER 6: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Product Type
    • 6.2.3 North America Market size and forecast, by Animal Type
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Product Type
      • 6.2.4.1.2 Market size and forecast, by Animal Type
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Product Type
      • 6.2.4.2.2 Market size and forecast, by Animal Type
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Product Type
      • 6.2.4.3.2 Market size and forecast, by Animal Type
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Product Type
    • 6.3.3 Europe Market size and forecast, by Animal Type
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Product Type
      • 6.3.4.1.2 Market size and forecast, by Animal Type
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Product Type
      • 6.3.4.2.2 Market size and forecast, by Animal Type
      • 6.3.4.3 U.K.
      • 6.3.4.3.1 Market size and forecast, by Product Type
      • 6.3.4.3.2 Market size and forecast, by Animal Type
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Product Type
      • 6.3.4.4.2 Market size and forecast, by Animal Type
      • 6.3.4.5 Rest of Europe
      • 6.3.4.5.1 Market size and forecast, by Product Type
      • 6.3.4.5.2 Market size and forecast, by Animal Type
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Product Type
    • 6.4.3 Asia-Pacific Market size and forecast, by Animal Type
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 China
      • 6.4.4.1.1 Market size and forecast, by Product Type
      • 6.4.4.1.2 Market size and forecast, by Animal Type
      • 6.4.4.2 India
      • 6.4.4.2.1 Market size and forecast, by Product Type
      • 6.4.4.2.2 Market size and forecast, by Animal Type
      • 6.4.4.3 Japan
      • 6.4.4.3.1 Market size and forecast, by Product Type
      • 6.4.4.3.2 Market size and forecast, by Animal Type
      • 6.4.4.4 South Korea
      • 6.4.4.4.1 Market size and forecast, by Product Type
      • 6.4.4.4.2 Market size and forecast, by Animal Type
      • 6.4.4.5 Rest of Asia-Pacific
      • 6.4.4.5.1 Market size and forecast, by Product Type
      • 6.4.4.5.2 Market size and forecast, by Animal Type
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Product Type
    • 6.5.3 LAMEA Market size and forecast, by Animal Type
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Latin America
      • 6.5.4.1.1 Market size and forecast, by Product Type
      • 6.5.4.1.2 Market size and forecast, by Animal Type
      • 6.5.4.2 Middle East
      • 6.5.4.2.1 Market size and forecast, by Product Type
      • 6.5.4.2.2 Market size and forecast, by Animal Type
      • 6.5.4.3 Africa
      • 6.5.4.3.1 Market size and forecast, by Product Type
      • 6.5.4.3.2 Market size and forecast, by Animal Type

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Bayer AG
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Eli Lilly and Company
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Boehringer
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Ingelheim GmbH
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 Merck and Co.
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Zoetis Inc.
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 Ceva Sante Animale
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Sanofi S.A.
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Nutreco N.V.
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Virbac S.A.
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
  • TABLE 2. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR ANIMAL DIAGNOSTICS PRODUCTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 3. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANIMAL DIAGNOSTICS PRODUCTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 4. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR ANIMAL THERAPEUTICS PRODUCTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 5. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANIMAL THERAPEUTICS PRODUCTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 6. GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
  • TABLE 7. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR COMPANION ANIMALS, BY REGION , 2020-2030,($MILLION)
  • TABLE 8. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET COMPANION ANIMALS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 9. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR CATTLE, BY REGION , 2020-2030,($MILLION)
  • TABLE 10. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET CATTLE BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 11. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR PIGS, BY REGION , 2020-2030,($MILLION)
  • TABLE 12. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET PIGS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 13. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR POULTRY, BY REGION , 2020-2030,($MILLION)
  • TABLE 14. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET POULTRY BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 15. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET REVENUE, FOR SHEEP, BY REGION , 2020-2030,($MILLION)
  • TABLE 16. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SHEEP BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 17. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION, 2020-2030,($MILLION)
  • TABLE 18. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
  • TABLE 19. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
  • TABLE 20. NORTH AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 21. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 22. U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 23. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 24. CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 25. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 26. MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 27. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
  • TABLE 28. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
  • TABLE 29. EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 30. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 31. GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 32. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 33. FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 34. U.K. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 35. U.K. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 36. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 37. ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 38. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 39. REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 40. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
  • TABLE 41. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
  • TABLE 42. ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 43. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 44. CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 45. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 46. INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 47. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 48. JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 49. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 50. SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 51. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 52. REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 53. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2020-2030,($MILLION)
  • TABLE 54. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020-2030,($MILLION)
  • TABLE 55. LAMEA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 56. LATIN AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 57. LATIN AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 58. MIDDLE EAST ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 59. MIDDLE EAST ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 60. AFRICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY PRODUCT TYPE 2020-2030,($MILLION)
  • TABLE 61. AFRICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY ANIMAL TYPE 2020-2030,($MILLION)
  • TABLE 62.BAYER AG: COMPANY SNAPSHOT
  • TABLE 63.BAYER AG: OPERATING SEGMENTS
  • TABLE 64.BAYER AG: PRODUCT PORTFOLIO
  • TABLE 65.BAYER AG: NET SALES,
  • TABLE 66.BAYER AG: KEY STRATERGIES
  • TABLE 67.ELI LILLY AND COMPANY: COMPANY SNAPSHOT
  • TABLE 68.ELI LILLY AND COMPANY: OPERATING SEGMENTS
  • TABLE 69.ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 70.ELI LILLY AND COMPANY: NET SALES,
  • TABLE 71.ELI LILLY AND COMPANY: KEY STRATERGIES
  • TABLE 72.BOEHRINGER: COMPANY SNAPSHOT
  • TABLE 73.BOEHRINGER: OPERATING SEGMENTS
  • TABLE 74.BOEHRINGER: PRODUCT PORTFOLIO
  • TABLE 75.BOEHRINGER: NET SALES,
  • TABLE 76.BOEHRINGER: KEY STRATERGIES
  • TABLE 77.INGELHEIM GMBH: COMPANY SNAPSHOT
  • TABLE 78.INGELHEIM GMBH: OPERATING SEGMENTS
  • TABLE 79.INGELHEIM GMBH: PRODUCT PORTFOLIO
  • TABLE 80.INGELHEIM GMBH: NET SALES,
  • TABLE 81.INGELHEIM GMBH: KEY STRATERGIES
  • TABLE 82.MERCK AND CO.: COMPANY SNAPSHOT
  • TABLE 83.MERCK AND CO.: OPERATING SEGMENTS
  • TABLE 84.MERCK AND CO.: PRODUCT PORTFOLIO
  • TABLE 85.MERCK AND CO.: NET SALES,
  • TABLE 86.MERCK AND CO.: KEY STRATERGIES
  • TABLE 87.ZOETIS INC.: COMPANY SNAPSHOT
  • TABLE 88.ZOETIS INC.: OPERATING SEGMENTS
  • TABLE 89.ZOETIS INC.: PRODUCT PORTFOLIO
  • TABLE 90.ZOETIS INC.: NET SALES,
  • TABLE 91.ZOETIS INC.: KEY STRATERGIES
  • TABLE 92.CEVA SANTE ANIMALE: COMPANY SNAPSHOT
  • TABLE 93.CEVA SANTE ANIMALE: OPERATING SEGMENTS
  • TABLE 94.CEVA SANTE ANIMALE: PRODUCT PORTFOLIO
  • TABLE 95.CEVA SANTE ANIMALE: NET SALES,
  • TABLE 96.CEVA SANTE ANIMALE: KEY STRATERGIES
  • TABLE 97.SANOFI S.A.: COMPANY SNAPSHOT
  • TABLE 98.SANOFI S.A.: OPERATING SEGMENTS
  • TABLE 99.SANOFI S.A.: PRODUCT PORTFOLIO
  • TABLE 100.SANOFI S.A.: NET SALES,
  • TABLE 101.SANOFI S.A.: KEY STRATERGIES
  • TABLE 102.NUTRECO N.V.: COMPANY SNAPSHOT
  • TABLE 103.NUTRECO N.V.: OPERATING SEGMENTS
  • TABLE 104.NUTRECO N.V.: PRODUCT PORTFOLIO
  • TABLE 105.NUTRECO N.V.: NET SALES,
  • TABLE 106.NUTRECO N.V.: KEY STRATERGIES
  • TABLE 107.VIRBAC S.A.: COMPANY SNAPSHOT
  • TABLE 108.VIRBAC S.A.: OPERATING SEGMENTS
  • TABLE 109.VIRBAC S.A.: PRODUCT PORTFOLIO
  • TABLE 110.VIRBAC S.A.: NET SALES,
  • TABLE 111.VIRBAC S.A.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET SEGMENTATION
  • FIGURE 2.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030
  • FIGURE 3.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,BY PRODUCT TYPE,2020(%)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ANIMAL DIAGNOSTICS PRODUCTS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF ANIMAL THERAPEUTICS PRODUCTS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 14.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,BY ANIMAL TYPE,2020(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF COMPANION ANIMALS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CATTLE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PIGS ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF POULTRY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SHEEP ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030(%)
  • FIGURE 20.ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET BY REGION,2020
  • FIGURE 21.U.S. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 22.CANADA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 23.MEXICO ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 24.GERMANY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 25.FRANCE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 26.U.K. ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 27.ITALY ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 28.REST OF EUROPE ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 29.CHINA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 30.INDIA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 31.JAPAN ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 32.SOUTH KOREA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 33.REST OF ASIA-PACIFIC ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 34.LATIN AMERICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 35.MIDDLE EAST ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 36.AFRICA ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET,2020-2030($MILLION)
  • FIGURE 37. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 38. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 39. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 40.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 41.COMPETITIVE DASHBOARD
  • FIGURE 42.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 43.BAYER AG.: NET SALES ,($MILLION)
  • FIGURE 44.ELI LILLY AND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 45.BOEHRINGER.: NET SALES ,($MILLION)
  • FIGURE 46.INGELHEIM GMBH.: NET SALES ,($MILLION)
  • FIGURE 47.MERCK AND CO..: NET SALES ,($MILLION)
  • FIGURE 48.ZOETIS INC..: NET SALES ,($MILLION)
  • FIGURE 49.CEVA SANTE ANIMALE.: NET SALES ,($MILLION)
  • FIGURE 50.SANOFI S.A..: NET SALES ,($MILLION)
  • FIGURE 51.NUTRECO N.V..: NET SALES ,($MILLION)
  • FIGURE 52.VIRBAC S.A..: NET SALES ,($MILLION)